Last reviewed · How we verify
BYON5667 & SYD985
At a glance
| Generic name | BYON5667 & SYD985 |
|---|---|
| Also known as | BYON5667: sodium thiosulfate, SYD985: (vic-)trastuzumab duocarmazine |
| Sponsor | Byondis B.V. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- BYON5667 & SYD985 CI brief — competitive landscape report
- BYON5667 & SYD985 updates RSS · CI watch RSS
- Byondis B.V. portfolio CI